Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 795   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Genetic polymorphisms associated with circadian rhythm dysregulation provide new perspectives on bipolar disorder
Thomaz Oliveira,Victor Marinho,Valécia Carvalho,Francisco Magalhăes,Kaline Rocha,Carla Ayres,Silmar Teixeira,Monara Nunes,Victor Hugo Bastos,Giovanny R Pinto
Bipolar Disorders.2018;20(6)515
2Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy
Vikas Jhawat,Monika Gulia,Sumeet Gupta,Balaji Maddiboyina,Rohit Dutt
Journal of Controlled Release.2020;327(6)500
3Carbamazepine adverse drug reactions
Ingrid Fricke-Galindo,Adrián LLerena,Helgi Jung-Cook,Marisol López-López
Expert Review of Clinical Pharmacology.2018;11(7)705
4The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients
Tatiana Tverdohleb,Bora Dinc,Ivana Knezevic,Kenneth D. Candido,Nebojsa Nick Knezevic
Expert Opinion on Drug Metabolism & Toxicology.2016;12(11)1303

Most popular articles
Join us as a reviewer
Email alerts
Recommend this journal